MEI Pharma Dividende
Zukünftiges Wachstum Kriterienprüfungen 2/6
MEI Pharma is a dividend paying company with a current yield of 57%.
Wichtige Informationen
57.0%
Dividendenausschüttung
0%
Rückkaufsrendite
| Gesamte Aktionärsrendite | 0% |
| Zukünftige Dividendenrendite | n/a |
| Wachstum der Dividende | n/a |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | n/a |
| Ausschüttungsquote | n/a |
Aktuelle Dividendenentwicklung
Recent updates
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 17
Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)
Dec 30Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)
Nov 19We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely
May 18Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022
Mar 26Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts
Feb 12MEI Pharma: Another PI3K Delta Progressing To The FDA
Feb 01Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates
Dec 02We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate
Nov 04MEI Pharma EPS misses by $0.12, misses on revenue
May 06MEI Pharma promotes Richard Ghalie to chief medical officer
Apr 30MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued
Apr 26The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding
Feb 25New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)
Feb 11
Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Insufficient data to determine if MEIP's dividends per share have been stable in the past.
Wachsende Dividende: Insufficient data to determine if MEIP's dividend payments have been increasing.
Dividendenrendite im Vergleich zum Markt
| MEI Pharma Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (MEIP) | 57.0% |
| Untere 25 % des Marktes (US) | 1.5% |
| Markt Top 25 % (US) | 4.5% |
| Branchendurchschnitt (Biotechs) | 2.2% |
| Analystenprognose (MEIP) (bis zu 3 Jahre) | n/a |
Bemerkenswerte Dividende: MEIP's dividend (57%) is higher than the bottom 25% of dividend payers in the US market (1.46%).
Hohe Dividende: MEIP's dividend (57%) is in the top 25% of dividend payers in the US market (4.55%)
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Insufficient data to calculate MEIP's payout ratio to determine if its dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Unable to calculate sustainability of dividends as MEIP has not reported any payouts.